To generate a Claudin-2 knockout in human HT-29 CRC, independent clones were first screened by immunoblot analysis to identify those with Claudin-2 loss and a pool of three Claudin-2 knockout clones was generated (Cldn2KO; Fig. 1a). The gene discussed is CLDN2; the disease is colorectal carcinoma.